Verona Pharma PLC (NAS:VRNA)
$ 30.01 -0.16 (-0.53%) Market Cap: 2.44 Bil Enterprise Value: 2.17 Bil PE Ratio: 0 PB Ratio: 14.42 GF Score: 29/100

Q4 2020 Verona Pharma PLC Earnings Call Transcript

Feb 25, 2021 / 02:00PM GMT
Release Date Price: $9.3 (+1.75%)
Operator

Welcome to Verona Pharma's Fourth Quarter and Year-End 2020 Financial Results and Operating Highlights Conference Call. (Operator Instructions)

Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3 months and full year ended December 31, 2020. A copy can be found in the Investor Relations tab on the corporate website www.veronapharma.com.

Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward-looking statements. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from our expectations expressed or implied by the forward-looking statements, including, without limitation, the impact of COVID-19 pandemic on the status, recruitment,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot